Free Trial

111 (YI) Stock Price, News & Analysis

111 logo
$8.24 -0.01 (-0.12%)
Closing price 05/30/2025 03:59 PM Eastern
Extended Trading
$8.24 0.00 (0.00%)
As of 05/30/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About 111 Stock (NASDAQ:YI)

Key Stats

Today's Range
$6.91
$8.25
50-Day Range
$6.15
$9.86
52-Week Range
$4.15
$12.90
Volume
16,124 shs
Average Volume
24,082 shs
Market Capitalization
$71.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.

111 Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
10th Percentile Overall Score

YI MarketRank™: 

111 scored higher than 10% of companies evaluated by MarketBeat, and ranked 889th out of 934 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for 111.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of 111 is -2.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of 111 is -2.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about 111's valuation and earnings.
  • Percentage of Shares Shorted

    0.11% of the float of 111 has been sold short.
  • Short Interest Ratio / Days to Cover

    111 has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in 111 has recently decreased by 1.79%, indicating that investor sentiment is improving.
  • Dividend Yield

    111 does not currently pay a dividend.

  • Dividend Growth

    111 does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.11% of the float of 111 has been sold short.
  • Short Interest Ratio / Days to Cover

    111 has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in 111 has recently decreased by 1.79%, indicating that investor sentiment is improving.
  • News Sentiment

    111 has a news sentiment score of -0.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.87 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 10 news articles for 111 this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, 111 insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    43.90% of the stock of 111 is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 21.32% of the stock of 111 is held by institutions.

  • Read more about 111's insider trading history.
Receive YI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 111 and its competitors with MarketBeat's FREE daily newsletter.

YI Stock News Headlines

URGENT: Someone's Moving Gold Out of London...
People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold.
See More Headlines

YI Stock Analysis - Frequently Asked Questions

111's stock was trading at $6.23 at the beginning of 2025. Since then, YI stock has increased by 32.3% and is now trading at $8.24.
View the best growth stocks for 2025 here
.

111, Inc. (NASDAQ:YI) released its quarterly earnings data on Thursday, March, 20th. The company reported ($0.04) earnings per share for the quarter. The business earned $527.14 million during the quarter.
Read the conference call transcript
.

111 shares reverse split on the morning of Friday, January 24th 2025. The 1-10 reverse split was announced on Wednesday, January 8th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, January 23rd 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

111 (YI) raised $140 million in an initial public offering (IPO) on Wednesday, September 12th 2018. The company issued 9,300,000 shares at $14.00-$16.00 per share. J.P. Morgan, Citigroup and CICC served as the underwriters for the IPO.

Top institutional investors of 111 include Connor Clark & Lunn Investment Management Ltd. (0.13%) and Deuterium Capital Management LLC (0.12%).

Shares of YI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that 111 investors own include NVIDIA (NVDA), Teladoc Health (TDOC), Innovative Industrial Properties (IIPR), Magnite (MGNI), Roku (ROKU), Twilio (TWLO).

Company Calendar

Last Earnings
3/20/2025
Today
5/31/2025
Next Earnings (Estimated)
6/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Drug stores & proprietary stores
Sub-Industry
Retail
Current Symbol
NASDAQ:YI
Fax
N/A
Employees
2,110
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$43.07 million
Pretax Margin
-1.48%

Debt

Sales & Book Value

Annual Sales
$14.40 billion
Price / Cash Flow
N/A
Book Value
($9.79) per share
Price / Book
-0.84

Miscellaneous

Free Float
4,798,000
Market Cap
$71.23 million
Optionable
Optionable
Beta
0.47
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:YI) was last updated on 5/31/2025 by MarketBeat.com Staff
From Our Partners